(Corrects Eli Lilly (NYSE: LLY ) trial in paragraph 4 to antibody treatment, not vaccine)
TOKYO, Oct 14 (Reuters) - Japan's stock benchmark Nikkei recouped early losses on Wednesday to close marginally higher, but sentiment remained subdued over stalled COVID-19 vaccine trials and lack of agreement on additional U.S. fiscal stimulus.
Tokyo shares followed Wall Street lower in early trade before reversing course in the afternoon, which analysts suspected was due to the Bank of Japan's exchange-traded fund buying.
On Tuesday, major indexes on Wall Street ended lower as Johnson & Johnson JNJ.N and Eli Lilly and Co LLY.N halted coronavirus vaccine and antibody treatment trials, respectively, over safety concerns, dampening investor sentiment. hopes for a new U.S. coronavirus relief package also weighed on the market, as U.S. House Speaker Nancy Pelosi rejected a $1.8 trillion coronavirus relief proposal from the White House. home, Apple-related issues underperformed on profit-taking and dented by a 2.7% fall in Apple Inc AAPL.O shares following an event where the company unveiled its latest iPhone. Corp 6762.T edged 0.08% lower, while Taiyo Yuden 6976.T fell 0.27%.
"The moves are quite subtle when only looking at the Nikkei share average. But the Mothers Index is renewing highs and semiconductor stocks are still strongly sought after," said Takashi Hiroki, chief strategist at Monex Securities.
The Mothers Index .MTHR of start-up firms gained 1.37%, posting its highest close since January 2018.
Elsewhere, ANA Holdings 9202.T dipped 4.59% after reports that the company was going to cut monthly wages for all workers by 5%. Steel 5401.T lost 3.82% on news that the company would sell two U.S. plants as it speeds up a reorganisation in overseas operations.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.